37679 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 30
00:14 UTC
|
TXG
10x Genomics
|
◎ Target | Mike Kratky ★★★★★ #295 | Market Perform | $40.00→ $90.00+125.0% |
|
Sep 30
00:14 UTC
|
TWST
Twist Bioscience
|
◎ Target | Puneet Souda ★★★★★ #60 | Outperform | $160.00→ $190.00+18.8% |
|
Sep 30
00:14 UTC
|
TRU
TransUnion
|
◎ Target | George Tong ★★☆☆☆ #2268 | Neutral | $89.00→ $77.00-13.5% |
|
Sep 30
00:14 UTC
|
TMUS
T-Mobile US
|
◎ Target | Kannan Venkateshwar ★★★☆☆ #2013 | Overweight | $215.00→ $200.00-7.0% |
|
Sep 30
00:14 UTC
|
SYY
Sysco
|
◎ Target | John Ivankoe ★★★☆☆ #1838 | Overweight | $100.00→ $95.00-5.0% |
|
Sep 30
00:14 UTC
|
SNWS
Smiths News
|
◎ Target | firm only | Buy | GBX 85→ GBX 88+3.5% |
|
Sep 30
00:14 UTC
|
SMG
Scotts Miracle-Gro
|
◎ Target | W. Andrew Carter ★★☆☆☆ #2745 | Buy | $76.00→ $75.00-1.3% |
|
Sep 30
00:14 UTC
|
SHAK
Shake Shack
|
◎ Target | John Ivankoe ★★★☆☆ #1838 | Neutral | $77.00→ $75.00-2.6% |
|
Sep 30
00:14 UTC
|
SG
Sweetgreen
|
◎ Target | Logan Reich ★★☆☆☆ #2706 | Outperform | $6.50→ $11.00+69.2% |
|
Sep 30
00:14 UTC
|
SBUX
Starbucks
|
◎ Target | John Ivankoe ★★★☆☆ #1838 | Overweight | $112.00→ $105.00-6.2% |
|
Sep 30
00:14 UTC
|
ROL
Rollins
|
◎ Target | Seth Weber ★★★☆☆ #1068 | Neutral | $44.00→ $35.00-20.5% |
|
Sep 30
00:14 UTC
|
ROL
Rollins
|
◎ Target | Toni Kaplan ★★★☆☆ #1219 | Overweight | $60.00→ $45.00-25.0% |
|
Sep 30
00:14 UTC
|
QSR
Restaurant Brands International
|
◎ Target | John Ivankoe ★★★☆☆ #1838 | Overweight | $82.00→ $78.00-4.9% |
|
Sep 30
00:14 UTC
|
QSR
Restaurant Brands International
|
◎ Target | John Ivankoe ★★★☆☆ #1838 | Overweight | $82.00→ $78.00-4.9% |
|
Sep 30
00:14 UTC
|
PRM
Perimeter Solutions
|
◎ Target | Joshua Spector ★★☆☆☆ #2716 | Buy | $42.00→ $38.00-9.5% |
|
Sep 30
00:14 UTC
|
PAGS
PagSeguro Digital
|
◎ Target | Kaio Prato not yet tracked | Buy | $12.50→ $11.00-12.0% |
|
Sep 30
00:14 UTC
|
OPRX
OptimizeRx
|
◎ Target | Anderson Schock ★★★☆☆ #2123 | Buy | $10.00→ $11.00+10.0% |
|
Sep 30
00:14 UTC
|
OKTA
Okta
|
◎ Target | Meta Marshall ★★★★☆ #830 | Overweight | $200.00→ $245.00+22.5% |
|
Sep 30
00:14 UTC
|
NXRT
NexPoint Residential Trust
|
◎ Target | Michael Lewis ★★☆☆☆ #2653 | Hold | $26.00→ $18.00-30.8% |
|
Sep 30
00:14 UTC
|
NUAI
New Era Energy & Digital
|
◎ Target | Nick Giles ★★☆☆☆ #2479 | Buy | $10.00→ $13.00+30.0% |
|
Sep 30
00:14 UTC
|
NKE
NIKE
|
◎ Target | Piral Dadhania not yet tracked | Sec→ r Perform | $45.00→ $40.00-11.1% |
|
Sep 30
00:14 UTC
|
NESR
National Energy Services Reunited
|
◎ Target | Josh Silverstein ★★★☆☆ #1828 | Buy | $47.00→ $46.00-2.1% |
|
Sep 30
00:14 UTC
|
NBIX
Neurocrine Biosciences
|
◎ Target | Ashwani Verma ★★★★☆ #878 | Buy | $231.00→ $214.00-7.4% |
|
Sep 30
00:14 UTC
|
MUR
Murphy Oil
|
◎ Target | Sam Margolin ★★★☆☆ #1275 | Equal Weight | $42.00→ $43.00+2.4% |
|
Sep 30
00:14 UTC
|
MTN
Vail Resorts
|
◎ Target | Patrick Scholes ★★☆☆☆ #2260 | Buy | $195.00→ $191.00-2.1% |
|
Sep 30
00:14 UTC
|
MTN
Vail Resorts
|
◎ Target | Ben Chaiken not yet tracked | Outperform | $160.00→ $156.00-2.5% |
|
Sep 30
00:14 UTC
|
MTN
Vail Resorts
|
◎ Target | Brandt Montour ★☆☆☆☆ #2992 | Underweight | $119.00→ $117.00-1.7% |
|
Sep 30
00:14 UTC
|
MTN
Vail Resorts
|
◎ Target | Chris Woronka ★★★☆☆ #1806 | Hold | $138.00→ $132.00-4.3% |
|
Sep 30
00:14 UTC
|
MTN
Vail Resorts
|
◎ Target | Matthew Boss ★★☆☆☆ #2558 | Neutral | $126.00→ $150.00+19.0% |
|
Sep 30
00:14 UTC
|
MTN
Vail Resorts
|
◎ Target | Anthony Bonadio ★★★★☆ #832 | Equal Weight | $125.00→ $130.00+4.0% |
|
Sep 30
00:14 UTC
|
MTEC
Made Tech Group
|
◎ Target | firm only | Buy | GBX 60→ GBX 70+16.7% |
|
Sep 30
00:14 UTC
|
MSCI
MSCI
|
◎ Target | Jason Haas not yet tracked | Overweight | $690.00→ $685.00-0.7% |
|
Sep 30
00:14 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Louise Chen ★★★★☆ #601 | Sec→ r Outperform | $155.00→ $180.00+16.1% |
|
Sep 30
00:14 UTC
|
MNR
Mach Natural Resources
|
◎ Target | John Freeman ★★★★☆ #614 | Strong-Buy | $19.00→ $16.00-15.8% |
|
Sep 30
00:14 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Brian Skorney ★★★☆☆ #1187 | Outperform | $123.00→ $130.00+5.7% |
|
Sep 30
00:14 UTC
|
MCD
McDonald's
|
◎ Target | John Ivankoe ★★★☆☆ #1838 | Overweight | $260.00→ $250.00-3.8% |
|
Sep 30
00:14 UTC
|
KIM
Kimco Realty
|
◎ Target | Ronald Kamdem ★★☆☆☆ #2483 | Equal Weight | $24.00→ $25.00+4.2% |
|
Sep 30
00:14 UTC
|
JNJ
Johnson & Johnson
|
◎ Target | Chris Schott ★★★☆☆ #1326 | Neutral | $270.00→ $285.00+5.6% |
|
Sep 30
00:14 UTC
|
JMKE
Jersey Mike's
|
◎ Target | John Ivankoe ★★★☆☆ #1838 | Overweight | $26.00→ $24.00-7.7% |
|
Sep 30
00:14 UTC
|
JMKE
Jersey Mike's
|
◎ Target | John Ivankoe ★★★☆☆ #1838 | Overweight | $26.00→ $24.00-7.7% |
|
Sep 30
00:14 UTC
|
JEF
Jefferies Financial Group
|
◎ Target | Chris Kotowski ★★★☆☆ #1559 | Outperform | $76.00→ $71.00-6.6% |
|
Sep 30
00:14 UTC
|
JEF
Jefferies Financial Group
|
◎ Target | James Yaro ★★☆☆☆ #2380 | Buy | $67.00→ $57.00-14.9% |
|
Sep 30
00:14 UTC
|
JEF
Jefferies Financial Group
|
◎ Target | Brennan Hawken ★★★☆☆ #1077 | Market Perform | $57.00→ $50.00-12.3% |
|
Sep 30
00:14 UTC
|
JEF
Jefferies Financial Group
|
◎ Target | Ryan Kenny ★★☆☆☆ #2623 | Equal Weight | $50.00→ $49.00-2.0% |
|
Sep 30
00:14 UTC
|
IREN
IREN
|
◎ Target | Lucas Pipes not yet tracked | Buy | $96.00→ $91.00-5.2% |
|
Sep 30
00:14 UTC
|
IQV
IQVIA
|
◎ Target | Ryan Halsted ★★★☆☆ #1627 | Outperform | $247.00→ $319.00+29.1% |
|
Sep 30
00:14 UTC
|
IOVA
Iovance Biotherapeutics
|
◎ Target | Joseph Pantginis ★★☆☆☆ #2767 | Buy | $9.00→ $20.00+122.2% |
|
Sep 30
00:14 UTC
|
IMMX
Immix Biopharma
|
◎ Target | Gil Blum ★★☆☆☆ #2392 | Buy | $21.00→ $30.00+42.9% |
|
Sep 30
00:14 UTC
|
ILMN
Illumina
|
◎ Target | Puneet Souda ★★★★★ #60 | Outperform | $220.00→ $300.00+36.4% |
|
Sep 30
00:14 UTC
|
HOOD
Robinhood Markets
|
◎ Target | Brian Bedell ★★★★☆ #870 | Buy | $138.00→ $134.00-2.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.